| Literature DB >> 33867999 |
Itamar B Dias1, Hjalmar R Bouma1,2, Robert H Henning1.
Abstract
Tissue-resident stem cells may enter a dormant state, also known as quiescence, which allows them to withstand metabolic stress and unfavorable conditions. Similarly, hibernating mammals can also enter a state of dormancy used to evade hostile circumstances, such as food shortage and low ambient temperatures. In hibernation, the dormant state of the individual and its cells is commonly known as torpor, and is characterized by metabolic suppression in individual cells. Given that both conditions represent cell survival strategies, we here compare the molecular aspects of cellular quiescence, particularly of well-studied hematopoietic stem cells, and torpor at the cellular level. Critical processes of dormancy are reviewed, including the suppression of the cell cycle, changes in metabolic characteristics, and cellular mechanisms of dealing with damage. Key factors shared by hematopoietic stem cell quiescence and torpor include a reversible activation of factors inhibiting the cell cycle, a shift in metabolism from glucose to fatty acid oxidation, downregulation of mitochondrial activity, key changes in hypoxia-inducible factor one alpha (HIF-1α), mTOR, reversible protein phosphorylation and autophagy, and increased radiation resistance. This similarity is remarkable in view of the difference in cell populations, as stem cell quiescence regards proliferating cells, while torpor mainly involves terminally differentiated cells. A future perspective is provided how to advance our understanding of the crucial pathways that allow stem cells and hibernating animals to engage in their 'great slumbers.'Entities:
Keywords: cell cycle; cell dormancy; hibernation; metabolism; quiescence; torpor
Year: 2021 PMID: 33867999 PMCID: PMC8047423 DOI: 10.3389/fphys.2021.624950
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1The complex regulation of HSC – and possibly hibernators – cell cycle entry. Cyclin-CDK complexes drive the progression of the cell cycle. Their inhibition forces entry into quiescence from G1 into the G0 phase of the cell, mainly by the action of cyclin-dependent kinase inhibitors (CKI) from the INK and CIP/KIP family. Various pathways converge on the CKIs, thus instituting quiescence. Low activity of the PI3K/Akt/mTOR pathway is vital to enter quiescence, mainly through the inhibition of cyclin-D-CDK4/6 complexes and suppression of the Rb-E2F pathway. This pathway is massively regulated, primarily through inhibition by the tumor suppressors phosphatase and tensin homolog (PTEN) and tuberous sclerosis proteins 1 and 2 (TSC1/2). Furthermore, the activity of the cyclin D-CDK4/6 complexes is inhibited both by the Ink4 and CIP/KIP CKIs. The Cyclin E-CDK2 complex regulates progression from the G1 to the S phase, and it is mainly regulated by the CIP/KIP family of CKIs, as well as by tumor suppressors from the retinoblastoma protein family (Rb, p107, p130). Extrinsic signals activate the transcription factors HES1, JunB and FOXO3a expression, which in turn regulate the transcription of the CIP/KIP family members. Moreover, entry into cellular quiescence is also subject to regulation via the tumor suppressor p53, as a response to cellular damage. Solid arrows indicate direct activation pathways, solid T-lines indicate inhibitory pathways and dashed arrows indicate transcriptional regulation activity.
FIGURE 2Molecular mechanism governing cell quiescence and torpidity in contrast with cell proliferation and euthermia. Quiescent and torpid cells feature a metabolic shift from glucose fueled OXPHOS to FAO. Low nutrient supply leads to depletion of ATP which is detected by LKB1 that in turn activates AMPK, eliciting a downstream cascade including the activation of TSC1/2 that suppresses PI3K/Akt pathway and downstream ATP-expensive processes. AMPK further shuts down gene expression via activation of HDACs which tightly pack histone-DNA complexes into heterochromatin. Also, AMPK promotes autophagy by activating ULK1/ATG7, lipolysis and fatty acid oxidation via activation of OXPHOS regulator FOXOs proteins and PGC-1α. In addition, PGC-1α, a transcriptional coregulator of PPAR target genes, promotes the upregulation of PPARδ. The PML-PPARδ-FAO further promotes β-oxidation of lipids and the metabolic shift toward FAO. HIF-1α promotes FAO via upregulation of PDK4 and inhibition of the first step in the TCA cycle, and promotes resistance to hypoxia stress and ROS damage. HIF-1α can be activated by its upstream regulator the Meis1 protein, which is activated by the elevation of intracellular ROS, and by low levels of O2. Dotted lines represent a restricted generation of molecules pointed at. Solid lines represent activated pathways. T lines indicate the suppression of the pathway. AMPK, AMP-activated protein kinase; ATG7, autophagy related 7; FOXOs, forkhead proteins; HDACs, histone deacetylases; HIF-1α, hypoxia-inducible factor 1α; HIF-2α, hypoxia-inducible factor 2α; LKB1, liver kinase B1; OXPHOS, oxidative phosphorylation; PDK4, pyruvate dehydrogenase kinases 4; PGC-1a, peroxisome proliferator-activated receptor-coactivator 1α; PML, promyelocyte leukemia protein; PML, promyelocyte leukemia protein; PPARs, peroxisome proliferator-activated receptors; PTEN, phosphatase and tensin homolog; TCA, tricarboxylic acid cycle; TF, transcription factors; TSC1/2, tuberous sclerosis proteins 1 and 2.
Comparison of key events driving quiescence in cells to those found in torpid cells.